Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy

被引:90
作者
Shankland, SJ
Pippin, J
Pichler, RH
Gordon, KL
Friedman, S
Gold, LI
Johnson, RJ
Couser, WG
机构
[1] SAN FRANCISCO GEN HOSP,MED SERV,SAN FRANCISCO,CA 94110
[2] UNIV CALIF SAN FRANCISCO,CTR LIVER,SAN FRANCISCO,CA 94143
[3] NYU,MED CTR,DIV PATHOL,NEW YORK,NY 10012
关键词
D O I
10.1038/ki.1996.294
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In membranous nephropathy (MN) overproduction of matrix by glomerular epithelial cells (GEC) is believed to be responsible for glomerular basement membrane thickening and spikes. We studied experimental MN in rats (passive Heymann nephritis, PHN) at 5, 10 and 30 days. PHN rats exhibited a marked increase in GEC immunostaining for TGF-beta 2 at all time points. TGF-beta 3 staining was increased at day 10 only, and TGF-beta 1 was unchanged. Glomerular mRNA for TGF-beta 2 and -beta 3 was increased by day when urine protein increased, whereas TGF-beta 1 was not. TGF-beta 2 bioactivity was increased at day 5. There was also a marked increase in GEC immunostaining for TGF-beta receptor type I (T beta IR) and TGF-beta receptor type II (T beta IIR) at all time points in PHN. mRNA levels for both receptors increased at day 5. Increases in protein expression and mRNA levels for the TGF-beta 2 and -beta 3 isoforms, and T beta IR and T beta RII were prevented by complement depletion. We conclude that complement-mediated injury to the GEC in vivo is associated with the up-regulation of TGF-beta 2 and -beta 3 isoforms, an increase in TGF-beta 2 bioactivity,and an increase in T beta RI and T beta RII expression. This contrasts with changes in TGF-beta 1 reported in mesangial disease, suggesting that TGF-beta 2 and -beta 3 may be important in diseases of the GEC. The differential expression of TGF-beta isoforms and receptors map be important determinants of the GEC response to injury.
引用
收藏
页码:116 / 124
页数:9
相关论文
共 51 条
  • [1] ADLER S, 1986, AM J PATHOL, V123, P553
  • [2] CONTROL OF RAT GLOMERULAR EPITHELIAL-CELL GROWTH-INVITRO
    ADLER, S
    CHEN, X
    ENG, B
    [J]. KIDNEY INTERNATIONAL, 1990, 37 (04) : 1048 - 1054
  • [3] ALOUSI MA, 1969, AM J PATHOL, V54, P47
  • [4] BAKER PJ, 1989, AM J PATHOL, V135, P185
  • [5] SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1
    BORDER, WA
    OKUDA, S
    LANGUINO, LR
    SPORN, MB
    RUOSLAHTI, E
    [J]. NATURE, 1990, 346 (6282) : 371 - 374
  • [6] NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE
    BORDER, WA
    NOBLE, NA
    YAMAMOTO, T
    HARPER, JR
    YAMAGUCHI, Y
    PIERSCHBACHER, MD
    RUOSLAHTI, E
    [J]. NATURE, 1992, 360 (6402) : 361 - 364
  • [7] BORDER WA, 1994, NEW ENGL J MED, V331, P1286
  • [8] RAT MESANGIAL CELL HYPERTROPHY IN RESPONSE TO TRANSFORMING GROWTH-FACTOR-BETA-1
    CHOI, ME
    KIM, EG
    HUANG, Q
    BALLERMANN, BJ
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (05) : 948 - 958
  • [9] COUSER WG, 1990, J AM SOC NEPHROL, V1, P13
  • [10] COUSER WG, 1988, ANNU REV MED, V39, P517